Today's biopharmaceutical landscape demands a fundamental rethinking of outsourcing approaches that embrace collaboration, flexibility, and teams willing to meet halfway.
Kerri McCaul-Claus
Advertisement
Kerri McCaul-Claus is Vice President and Head of FSP Biometrics at Parexel.
Articles by Kerri McCaul-Claus
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA and EMA Align on Ten Principles to Guide Artificial Intelligence Use in Drug Development
2
New Phase II Data Suggest Maternal Nipocalimab Does Not Disrupt Infant Immune Development in Severe HDFN
3
De-Risking Development: Prioritizing Robustness in Trial Design
4
Clinical Operations Teams Adjust to Evidence and Engagement Gaps
5